hAT-N1a_Mam

Basic information Differential Expression Stage analysis Survival analysis Correlation analysis

The patients were classified into two groups based on the expression levels of TE families or the identification of TE-initiated transcripts. To assess the statistical difference in survival between the two groups, a log-rank test was performed. The hazard ratio (HR) and p-value were computed using the "survdiff" function from the "survival" package in R.

Tumor	HR	P_value
TCGA-LGG	1.86	0.01
TCGA-LIHC	1.30	0.26
TCGA-PRAD	0.59	0.34
TCGA-GBM	0.91	0.72
TCGA-TGCT	NA	1.00